Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Excitotoxicity-induced neuronal damage pathway describes a pathological process by which excessive or prolonged activation of glutamate receptors (notably NMDA and AMPA receptors) causes neuronal injury and cell death. Prolonged glutamate receptor activation results in sustained calcium influx, inducing a cascade involving mitochondrial dysfunction, production of reactive oxygen species, activation of degradative enzymes, and ultimately cell death via apoptosis, necrosis, or autophagy. Excitotoxicity is central to the pathogenesis of acute and chronic neurological disorders, including stroke, traumatic brain injury, epilepsy, and various neurodegenerative diseases.
Inhibit glutamate receptors to prevent Ca²⁺ influx and subsequent cell death.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Excitotoxicity-induced neuronal damage pathway.